Q1 2017

Filed May 22, 2017 · 10-Q · 52 days after period end · 0001121781-17-000030

Q1 2017 · 10-Q

Revenue

$21.00K

no prior Q1 2016 on file

Net Income

-$107.00K

N/M vs Q1 2016

EPS Diluted

-$0.22

— vs Q1 2016

Gross Profit$5,000−97.4%

Operating Income

Same quarter

Metric	Q1 2017	Q1 2016	Q1 2015	Q1 2014
Revenue	$21.00K	—	—	$19.00K
Net Income	-$107.00K	$130.00K	-$1.25M	-$1.56M
EPS Diluted	-$0.22	$0.00	-$1.31	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR